A type of cell widely used for brain research and drug development may have been leading researchers astray for years, according to a study from scientists at Weill Cornell Medicine and Columbia University.
Poor function of the gene SMC3 can lead to improper immune cell development, and to cancer, by disrupting how DNA is structured inside the cell nucleus, according to new research from Weill Cornell Medicine.
Researchers at Weill Cornell Medicine and Cornell’s Ithaca campus have developed a new computational method for studying genetic and environmental interactions and how they influence disease risk.
A $10 million gift to the College of Architecture, Art and Planning has been given to the college by a multi-generational Cornellian family to name and permanently fund its NYC program.
The new, collaborative Precision Behavioral Health Initiative aims to use both smart devices and artificial intelligence to help individuals, and their doctors, monitor and manage behavioral health.
The Criminal Justice and Employment Initiative in November held the first two of four scheduled live online educational trainings for the Port Authority of New York and New Jersey’s Office of Second Chance Employment.
A Cornell-led COVID-19 patient registry, organized by Weill Cornell Medicine, continues to be a source of medical insight into the workings of the novel coronavirus and treatment of infected patients.
Space travel, illnesses like COVID-19 and climbing Mount Everest can trigger the body’s stress response systems in similar ways, according to new studies by Weill Cornell Medicine, space agencies and other investigators.
A team of Cornell scientists will use acoustic technology to develop efficient and affordable ways to manage soil-dwelling pests and their predators, thanks to a two-year grant from the USDA.
